[Experience with the medical treatment of chronic cerebrovascular insufficiency: bamethan and inositol nicotinate versus placebo].
D000368:Aged; D002545:Brain Ischemia / Q000188:drug therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007294:Inositol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008297:Male; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010919:Placebos; D014665:Vasodilator Agents / Q000627:therapeutic use*
D004983:Ethanolamines; D009539:Nicotinic Acids; D010919:Placebos; D014665:Vasodilator Agents; D007294:Inositol; C005193:Inositol Niacinate
Esperienza di terapia medica della insufficienza cerebrovascolare cronica: bamethan ed inositolo nicotinato versus placebo.